FDA Warning Letter — Prescription Labs Inc
The FDA took a Warning Letter action against Prescription Labs Inc on Oct 26, 2018 (Houston, TX). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Prescription Labs Inc
- Date
- Oct 26, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Houston, TX (United States)